1Gunduz K,Ozturk G,Terzioglu E.T cell subpopulations and IL2R in vitiligo[J].J Dermatol,2004,31(2):94-97.
2Mantovani S,Garbelli S,Palermo B.Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte specifi CD8+T cell sinone vitiligo patient[J].J Invest Dermatol,2003,121(2):308-314.
3Ozawa M,Ferenczi K,Kikuchi T,et al.312-nanometer ultraviolet B light(narrow-band UVB) induces apoptosis of T cells within psoriasis lesions[J].J Exp Med,1999,189(4):711-718.
4Moretti S,Spallanzani A,Amato L.New insight sinto the pathogenesis of vitiligo:imbalance of epidermal cytokines at sites of lesions[J].Pigment Cell Res,2002,15(2):87-92.
5Cui J,ShenL Y,Wang GC,et al.Role of hair follicles in the repigmentation of vitiligo[J].J Invest Dermatol,1991,97(3):410.
6Scherschun L,Kim JJ,Lim HW.Narrow band ultraviolet B is a useful and well tolerated treatment for vitiligo[J]J Am Acad Dermatol,2001,44(6):999-1003.
7Cucchi ML,Frattini P,Santagostino G,et al.Higher plasma catecholamine and metabolite levels in the early phase of nonsegental vitiligo[J].Pigment Cell Res,2000,13:28-32.
8Abdel Naser MB,Hann SK,Bystryn JC.Oral psoralen with UVA therpy release circulating growth facors that stimulates clee proliferation[J].Arch Dermatol,1997,133:1530-1533.
9Westerhof W.Nieuweboer-Kroboreova L.Treatment of Vitiligo with UV-B radiation vs topical psoralen plus UVA[J].Arch Dermatol,1997,33:1525-1528.
10Scherschun L,Kim JJ,Lim HW.Narrow band ultraviolet B is a useful and well tolerated treatment for vitiligo[J].J Am Acad Dermatol,2001,44:999-1003.